Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-02FDA Approved: TICAGRELOR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' generic ticagrelor (ANDA 208576) under an original application. Ticagrelor is an antiplatelet medicati…
-
FDA approval · 2025-05-01FDA Approved: TICAGRELOR — Original Application (Apotex Corp.)
FDA approved Apotex's original ANDA for ticagrelor, establishing a generic version of the antiplatelet medication.
-
FDA approval · 2025-04-04FDA Approved: TICAGRELOR — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for ticagrelor from Mylan Pharmaceuticals (ANDA 208597), allowing the generic ticagrelor product…
-
FDA approval · 2025-03-25FDA Approved: EPTIFIBATIDE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Eptifibatide from Sagent Pharmaceuticals.
-
FDA approval · 2025-02-25FDA Approved: CLOPIDOGREL — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for clopidogrel filed by NorthStar RxLLC under an ANDA. The action indicates regulatory clearance fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-15FDA Approved: EPTIFIBATIDE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter Healthcare's supplemental application for eptifibatide (brand Integrilin). This notice reflects a supplemental approval …
-
FDA approval · 2024-11-19FDA Approved: EPTIFIBATIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for the generic drug eptifibatide from Slate Run Pharmaceuticals, LLC, finalizing the regulatory act…
-
FDA approval · 2024-10-29FDA Approved: TICAGRELOR — Original Application (Dr. Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for ticagrelor (generic ticagrelor).
-
FDA approval · 2024-10-24FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indication…
-
FDA approval · 2024-08-20FDA Approved: PRASUGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's supplemental application for prasugrel, enabling a generic version of the antiplatelet drug. The approval is for the s…
-
FDA approval · 2024-08-16FDA Approved: TICAGRELOR — Original Application (Solco Healthcare U.S., LLC)
The FDA approved a generic ticagrelor product under an original Abbreviated New Drug Application submitted by Solco Healthcare U.S., LLC.
-
EMA approval · 2024-07-19EMA Authorised: DuoPlavin (clopidogrel;acetylsalicylic acid) — Sanofi Winthrop Industrie
DuoPlavin, a fixed-dose combination of clopidogrel and acetylsalicylic acid, has been authorised by the EMA for treatment in acute coronary …
-
FDA approval · 2024-05-29FDA Approved: PRASUGREL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for prasugrel from Accord Healthcare Inc., enabling a generic prasugrel product to be marketed. …
-
FDA approval · 2024-05-29FDA Approved: PRASUGREL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan’s supplemental application for prasugrel, enabling a generic version under ANDA205927.
-
FDA approval · 2024-05-09FDA Approved: EPTIFIBATIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application (ANDA) for a generic version of eptifibatide (Integrilin). The approval permits …
-
FDA approval · 2024-04-17FDA Approved: PRASUGREL — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for prasugrel submitted by Apotex Corp.
-
EMA approval · 2024-03-26EMA Authorised: Clopidogrel ratiopharm (clopidogrel (as hydrogen sulfate)) — Teva B.V.
European Medicines Agency authorises Clopidogrel ratiopharm (clopidogrel hydrogen sulfate) for multiple cardiovascular indications including…
-
EMA approval · 2024-02-29EMA Authorised: Clopidogrel Teva (hydrogen sulphate) (clopidogrel (as hydrogen sulfate)) — Teva Pharma B.V.
EMA authorised Clopidogrel Teva (hydrogen sulphate) for multiple cardiovascular indications including acute coronary syndrome, myocardial in…
-
EMA approval · 2023-12-19EMA Authorised: Clopidogrel Taw Pharma (previously Clopidogrel Mylan) (clopidogrel hydrochloride) — Taw Pharma (Ireland) Limited
EMA authorised a clopidogrel product (clopidogrel hydrochloride) by Taw Pharma (Ireland) Limited for peripheral vascular diseases, stroke, m…
-
FDA approval · 2023-11-21FDA Approved: BIVALIRUDIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for bivalirudin from Dr. Reddy's Laboratories Limited, indicating an approved change to an exist…
-
FDA approval · 2023-09-07FDA Approved: CLOPIDOGREL — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) by Apotex Corp., under the ANDA, authorizing a modif…
-
FDA approval · 2023-08-28FDA Approved: PRASUGREL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for prasugrel as a generic version (ANDA 213315) manufactured by Unichem Pharmaceuticals (USA), Inc. T…
-
FDA approval · 2023-07-24FDA Approved: TIROFIBAN HYDROCHLORIDE — Original Application (Nexus Pharmaceuticals LLC)
FDA approved the original application for tirofiban hydrochloride from Nexus Pharmaceuticals LLC, authorizing a generic tirofiban hydrochlor…
-
FDA approval · 2023-06-08FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for a generic clopidogrel product from Aurobindo Pharma Limited.
-
FDA approval · 2023-05-25FDA Approved: EPTIFIBATIDE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for the generic drug Eptifibatide filed by Eugia US LLC (ANDA 206127).